Kimberly-Clark Acquires Kenvue
Kimberly-Clark will purchase Kenvue, the maker of Tylenol, in a cash and stock acquisition valued at $48.7 billion.
Upon completion, Kimberly-Clark shareholders will own 54% of the combined company, while Kenvue shareholders will hold 46%.
The Merger
The merger brings together popular consumer brands, including Kenvue’s Tylenol, Listerine, and Band-Aid, and Kimberly-Clark’s Cottonelle, Huggies, and Kleenex.
Key Facts
- The takeover is one of the largest corporate deals announced in 2025.
- Kimberly-Clark Chairman and CEO Mike Hsu will lead the merged company.
- Three Kenvue board members will join Kimberly-Clark’s board upon closing.
We will serve billions of consumers across every stage of life.
Autor summary: Kimberly-Clark buys Kenvue for $48.7 billion.